Effectiveness of a dance-physiotherapy combined intervention in Parkinson's disease: a randomized controlled pilot trial.
Dance
Mind-body
Motor impairment
Parkinson’s disease
Physiotherapy
Rehabilitation
Journal
Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
ISSN: 1590-3478
Titre abrégé: Neurol Sci
Pays: Italy
ID NLM: 100959175
Informations de publication
Date de publication:
Dec 2021
Dec 2021
Historique:
received:
29
12
2020
accepted:
06
03
2021
pubmed:
21
3
2021
medline:
15
12
2021
entrez:
20
3
2021
Statut:
ppublish
Résumé
Physical therapies have been recommended as crucial components in Parkinson's disease (PD) rehabilitation. The study aims to examine the effectiveness of a new dance-physiotherapy combined intervention, called DArT method, in mild PD patients. A prospective, randomized, single-blind, controlled pilot trial was conducted on 38 mild PD patients under dopaminergic therapy. The intervention consisted in an add-on protocol: the control group received 1 h of conventional physiotherapy followed by 1 h of conventional physiotherapy each day, 3 times a week, for 5 weeks. The experimental group received 1 h of conventional physiotherapy followed by 1 h of dance class each day, 3 times a week, for 5 weeks. The week before and after the training period, patients were assessed for motor, cognitive, emotional, and sensory components of PD, with MDS-UPDRS-III as primary outcome measure. DArT method was associated with a 2.72-point reduction in the post-treatment MDS-UPDRS-III total score compared to control group (95% CI - 5.28, - 0.16, p = 0.038, d = 0.71), and with a 2.16-point reduction in the post-treatment MDS-UPDRS-III upper body subscore (95% CI - 3.56, - 0.76, p = 0.003, d = 1.02). Conversely, conventional physiotherapy program was associated with a 2.95-point reduction in the post-treatment trait anxiety compared to the experimental group (95% CI 0.19, 5.71, p = 0.037, d = 0.70). Withdrawal and fall rates were equal to 0% in both groups. DArT method showed to be safe, well accepted, and more effective than an intensive program of conventional physiotherapy in improving motor impairment in mild PD.
Sections du résumé
BACKGROUND
BACKGROUND
Physical therapies have been recommended as crucial components in Parkinson's disease (PD) rehabilitation.
OBJECTIVE
OBJECTIVE
The study aims to examine the effectiveness of a new dance-physiotherapy combined intervention, called DArT method, in mild PD patients.
METHODS
METHODS
A prospective, randomized, single-blind, controlled pilot trial was conducted on 38 mild PD patients under dopaminergic therapy. The intervention consisted in an add-on protocol: the control group received 1 h of conventional physiotherapy followed by 1 h of conventional physiotherapy each day, 3 times a week, for 5 weeks. The experimental group received 1 h of conventional physiotherapy followed by 1 h of dance class each day, 3 times a week, for 5 weeks. The week before and after the training period, patients were assessed for motor, cognitive, emotional, and sensory components of PD, with MDS-UPDRS-III as primary outcome measure.
RESULTS
RESULTS
DArT method was associated with a 2.72-point reduction in the post-treatment MDS-UPDRS-III total score compared to control group (95% CI - 5.28, - 0.16, p = 0.038, d = 0.71), and with a 2.16-point reduction in the post-treatment MDS-UPDRS-III upper body subscore (95% CI - 3.56, - 0.76, p = 0.003, d = 1.02). Conversely, conventional physiotherapy program was associated with a 2.95-point reduction in the post-treatment trait anxiety compared to the experimental group (95% CI 0.19, 5.71, p = 0.037, d = 0.70). Withdrawal and fall rates were equal to 0% in both groups.
CONCLUSION
CONCLUSIONS
DArT method showed to be safe, well accepted, and more effective than an intensive program of conventional physiotherapy in improving motor impairment in mild PD.
Identifiants
pubmed: 33743108
doi: 10.1007/s10072-021-05171-9
pii: 10.1007/s10072-021-05171-9
doi:
Types de publication
Journal Article
Randomized Controlled Trial
Langues
eng
Sous-ensembles de citation
IM
Pagination
5045-5053Subventions
Organisme : Innovative Clinical Trainings, Trials & Healthcare Worldwide Initiative
ID : KCL-001
Informations de copyright
© 2021. Fondazione Società Italiana di Neurologia.
Références
Postuma RB, Berg D, Stern M, Poewe W, Olanow CW, Oertel W, Obeso J, Marek K, Litvan I, Lang AE, Halliday G, Goetz CG, Gasser T, Dubois B, Chan P, Bloem BR, Adler CH, Deuschl G (2015) MDS clinical diagnostic criteria for Parkinson’s disease. Mov Disord 30:1591–1601. https://doi.org/10.1002/mds.26424
doi: 10.1002/mds.26424
pubmed: 26474316
Abbruzzese G, Marchese R, Avanzino L, Pelosin E (2016) Rehabilitation for Parkinson’s disease: current outlook and future challenges. Parkinsonism Relat Disord 22:S60–S64. https://doi.org/10.1016/j.parkreldis.2015.09.005
doi: 10.1016/j.parkreldis.2015.09.005
pubmed: 26360239
Sacheli MA, Murray DK, Vafai N, Cherkasova MV, Dinelle K, Shahinfard E, Neilson N, McKenzie J, Schulzer M, Appel-Cresswell S, McKeown MJ, Sossi V, Stoessl JA (2018) Habitual exercisers versus sedentary subjects with Parkinson’s disease: multimodal PET and fMRI study. Mov Disord 33:1945–1950. https://doi.org/10.1002/mds.27498
doi: 10.1002/mds.27498
pubmed: 30376184
Kwok JYY, Choi KC, Chan HYL (2016) Effects of mind–body exercises on the physiological and psychosocial well-being of individuals with Parkinson’s disease: a systematic review and meta-analysis. Complementary Ther Med 29:121–131. https://doi.org/10.1016/j.ctim.2016.09.016
doi: 10.1016/j.ctim.2016.09.016
Kalyani HHN, Sullivan K, Moyle G, Brauer S, Jeffrey ER, Roeder L, Berndt S, Kerr G (2019) Effects of dance on gait, cognition, and dual-tasking in Parkinson’s disease: a systematic review and meta-analysis. J Parkinsons Dis 9:335–349. https://doi.org/10.3233/JPD-181516
doi: 10.3233/JPD-181516
pubmed: 30958312
dos Santos Delabary M, Komeroski IG, Monteiro EP, Costa RR, Haas AN (2018) Effects of dance practice on functional mobility, motor symptoms and quality of life in people with Parkinson’s disease: a systematic review with meta-analysis. Aging Clin Exp Res 30:727–735. https://doi.org/10.1007/s40520-017-0836-2
doi: 10.1007/s40520-017-0836-2
pubmed: 28980176
Martinez-Martin P, Chaudhuri KR (2018) Comprehensive grading of Parkinson’s disease using motor and non-motor assessments: addressing a key unmet need. Expert Rev Neurother 18:41–50. https://doi.org/10.1080/14737175.2018.1400383
doi: 10.1080/14737175.2018.1400383
pubmed: 29090594
Biundo R, Weis L, Bostantjopoulou S, Stefanova E, Falup-Pecurariu C, Kramberger MG, Geurtsen GJ, Antonini A, Weintraub D, Aarsland D (2016) MMSE and MoCA in Parkinson’s disease and dementia with Lewy bodies: a multicenter 1-year follow-up study. J Neural Transm 123:431–438. https://doi.org/10.1007/s00702-016-1517-6
doi: 10.1007/s00702-016-1517-6
pubmed: 26852137
Keus SHJ, Bloem BR, Hendriks EJM, Bredero-Cohen AB, Munneke M, Practice Recommendations Development Group (2007) Evidence-based analysis of physical therapy in Parkinson’s disease with recommendations for practice and research. Mov Disord 22:451–460. https://doi.org/10.1002/mds.21244
doi: 10.1002/mds.21244
pubmed: 17133526
Tomlinson CL, Herd CP, Clarke CE, Meek C, Patel S, Stowe R, Deane KHO, Shah L, Sackley CM, Wheatley K, Ives N (2014) Physiotherapy for Parkinson’s disease: a comparison of techniques. Cochrane Database Systematic Rev CD002815. https://doi.org/10.1002/14651858.CD002815.pub2
Keus S, Munneke M, Graziano M, Paltamaa J, Pelosin E, Domingos J, Brühlmann S, Ramaswamy B, Prins J, Struiksma C, Rochester L, Nieuwboer A, Bloem B (2014) European physiotherapy guideline for Parkinson’s disease. https://www.parkinsonnet.com/discipline/physiotherapy . Accessed 2 Mar 2021
Goetz CG, Fahn S, Martinez-Martin P, Poewe W, Sampaio C, Stebbins GT, Stern MB, Tilley BC, Dodel R, Dubois B, Holloway R, Jankovic J, Kulisevsky J, Lang AE, Lees A, Leurgans S, LeWitt PA, Nyenhuis D, Olanow CW, Rascol O, Schrag A, Teresi JA, Van Hilten JJ, LaPelle N (2007) Movement Disorder Society-sponsored revision of the Unified Parkinson’s Disease Rating Scale (MDS-UPDRS): process, format, and clinimetric testing plan. Mov Disord 22:41–47. https://doi.org/10.1002/mds.21198
doi: 10.1002/mds.21198
pubmed: 17115387
Bouça-Machado R, Maetzler W, Ferreira JJ (2018) What is functional mobility applied to Parkinson’s disease? J Parkinsons Dis 8:121–130. https://doi.org/10.3233/JPD-171233
doi: 10.3233/JPD-171233
pubmed: 29480225
pmcid: 5836402
Nieuwboer A, Rochester L, Herman T, Vandenberghe W, Emil GE, Thomaes T, Giladi N (2009) Reliability of the new freezing of gait questionnaire: agreement between patients with Parkinson’s disease and their carers. Gait Posture 30:459–463. https://doi.org/10.1016/j.gaitpost.2009.07.108
doi: 10.1016/j.gaitpost.2009.07.108
pubmed: 19660949
Christofoletti G, Andrade LP, Beinotti F, Borges G (2014) Cognition and dual-task performance in older adults with Parkinson’s and Alzheimer’s disease. Int J Gen Med 7:383–388. https://doi.org/10.2147/IJGM.S65803
doi: 10.2147/IJGM.S65803
pubmed: 25092996
pmcid: 4113401
Peto V, Jenkinson C, Fitzpatrick R, Greenhall R (1995) The development and validation of a short measure of functioning and well being for individuals with Parkinson’s disease. Qual Life Res 4:241–248. https://doi.org/10.1007/BF02260863
doi: 10.1007/BF02260863
pubmed: 7613534
Visser M, Leentjens AFG, Marinus J, Stiggelbout AM, van Hilten JJ (2006) Reliability and validity of the Beck Depression Inventory in patients with Parkinson’s disease. Mov Disord 21:668–672. https://doi.org/10.1002/mds.20792
doi: 10.1002/mds.20792
pubmed: 16450355
Mondolo F, Jahanshahi M, Granà A, Biasutti E, Cacciatori E, Di Benedetto P (2007) Evaluation of anxiety in Parkinson’s disease with some commonly used rating scales. Neurol Sci 28:270–275. https://doi.org/10.1007/s10072-007-0834-9
doi: 10.1007/s10072-007-0834-9
pubmed: 17972042
Delbaere K, Close JCT, Mikolaizak AS, Sachdev PS, Brodaty H, Lord SR (2010) The Falls Efficacy Scale International (FES-I). A comprehensive longitudinal validation study. Age Ageing 39:210–216. https://doi.org/10.1093/ageing/afp225
doi: 10.1093/ageing/afp225
pubmed: 20061508
Chaudhuri KR, Rizos A, Trenkwalder C, Rascol O, Pal S, Martino D, Carroll C, Paviour D, Falup-Pecurariu C, Kessel B, Silverdale M, Todorova A, Sauerbier A, Odin P, Antonini A, Martinez-Martin P, EUROPAR and the IPMDS Non Motor PD Study Group (2015) King’s Parkinson’s disease pain scale, the first scale for pain in PD: an international validation. Mov Disord 30:1623–1631. https://doi.org/10.1002/mds.26270
doi: 10.1002/mds.26270
pubmed: 26096067
Nilsson MH, Bladh S, Hagell P (2013) Fatigue in Parkinson’s disease: measurement properties of a generic and a condition-specific rating scale. J Pain Symptom Manag 46:737–746. https://doi.org/10.1016/j.jpainsymman.2012.11.004
doi: 10.1016/j.jpainsymman.2012.11.004
Tomlinson CL, Stowe R, Patel S, Rick C, Gray R, Clarke CE (2010) Systematic review of levodopa dose equivalency reporting in Parkinson’s disease. Mov Disord 25:2649–2653. https://doi.org/10.1002/mds.23429
doi: 10.1002/mds.23429
pubmed: 21069833
Horváth K, Aschermann Z, Ács P, Deli G, Janszky J, Komoly S, Balázs E, Takács K, Karádi K, Kovács N (2015) Minimal clinically important difference on the motor examination part of MDS-UPDRS. Parkinsonism Relat Disord 21:1421–1426. https://doi.org/10.1016/j.parkreldis.2015.10.006
doi: 10.1016/j.parkreldis.2015.10.006
pubmed: 26578041
Steffen T, Seney M (2008) Test-retest reliability and minimal detectable change on balance and ambulation tests, the 36-Item Short-Form Health Survey, and the Unified Parkinson Disease Rating Scale in people with parkinsonism. Phys Ther 88:733–746. https://doi.org/10.2522/ptj.20070214
doi: 10.2522/ptj.20070214
pubmed: 18356292
Hulzinga F, Nieuwboer A, Dijkstra BW, Mancini M, Strouwen C, Bloem BR, Ginis P (2020) The New Freezing of Gait Questionnaire: unsuitable as an outcome in clinical trials? Mov Disord Clin Pract 7:199–205. https://doi.org/10.1002/mdc3.12893
doi: 10.1002/mdc3.12893
pubmed: 32071940
pmcid: 7011794
Godi M, Franchignoni F, Caligari M, Giordano A, Turcato AM, Nardone A (2013) Comparison of reliability, validity, and responsiveness of the Mini-BESTest and Berg Balance Scale in patients with balance disorders. Phys Ther 93:158–167. https://doi.org/10.2522/ptj.20120171
doi: 10.2522/ptj.20120171
pubmed: 23023812
Huang SL, Hsieh CL, Wu RM, Tai CH, Lin CH, Lu WS (2011) Minimal detectable change of the Timed “Up & Go” Test and the Dynamic Gait Index in people with Parkinson disease. Phys Ther 91:114–121. https://doi.org/10.2522/ptj.20090126
doi: 10.2522/ptj.20090126
pubmed: 20947672
Huang LS, Hsieh CL, Wu RM, Lu WS (2017) Test-retest reliability and minimal detectable change of the Beck Depression Inventory and the Taiwan Geriatric Depression Scale in patients with Parkinson’s disease. PLoS One 12:e0184823. https://doi.org/10.1371/journal.pone.0184823
doi: 10.1371/journal.pone.0184823
pubmed: 28945776
pmcid: 5612646
Jonasson SB, Nilsson MH, Lexell J (2014) Psychometric properties of four fear of falling rating scales in people with Parkinson’s disease. BMC Geriatr 14:66. https://doi.org/10.1186/1471-2318-14-66
doi: 10.1186/1471-2318-14-66
pubmed: 24884466
pmcid: 4035736
Horváth K, Aschermann Z, Kovács M, Makkos A, Harmat M, Janszky J, Komoly S, Karádi K, Kovács N (2017) Changes in quality of life in Parkinson’s disease: how large must they be to be relevant? Neuroepidemiology 48:1–8. https://doi.org/10.1159/000455863
doi: 10.1159/000455863
pubmed: 28161701
Siciliano M, Chiorri C, De Micco R, Russo A, Tedeschi G, Trojano L, Tessitore A (2019) Fatigue in Parkinson’s disease: Italian validation of the Parkinson Fatigue T Scale and the Fatigue Severity Scale using a Rasch analysis approach. Parkinsonism Relat Disord 65:105–110. https://doi.org/10.1016/j.parkreldis.2019.05.028
doi: 10.1016/j.parkreldis.2019.05.028
pubmed: 31147224
Berardelli A, Rothwell JC, Thompson PD, Hallett M (2001) Pathophysiology of bradykinesia in Parkinson’s disease. Brain 124:2131–2146. https://doi.org/10.1093/brain/124.11.2131
doi: 10.1093/brain/124.11.2131
pubmed: 11673316
Benedetti F, Carlino E, Frisaldi E, Piedimonte A, Zibetti M, Lanotte M, Lopiano L (2020) Placebo and nocebo responses in Parkinson’s disease. In: Martin CR, Preedy VR (eds) The neuroscience of Parkinson’s disease. Elsevier, San Diego ISBN-13: 9780128159583
Frisaldi E, Carlino E, Zibetti M, Barbiani D, Dematteis F, Lanotte M, Lopiano L, Benedetti F (2017) The placebo effect on bradykinesia in Parkinson’s disease with and without prior drug conditioning. Mov Disord 32:1474–1478. https://doi.org/10.1002/mds.27142
doi: 10.1002/mds.27142
pubmed: 28895186
Dietrich A, McDaniel WF (2004) Endocannabinoids and exercise. Br J Sports Med 38:536–541. https://doi.org/10.1136/bjsm.2004.011718
doi: 10.1136/bjsm.2004.011718
pubmed: 15388533
pmcid: 1724924
Nombela C, Hughes LE, Owen AM, Grahn JA (2013) Into the groove: can rhythm influence Parkinson’s disease? Neurosci Biobehav Rev 37:2564–2570. https://doi.org/10.1016/j.neubiorev.2013.08.003
doi: 10.1016/j.neubiorev.2013.08.003
pubmed: 24012774
De Bartolo D, Morone G, Giordani G, Antonucci G, Russo V, Fusco A, Marinozzi F, Bini F, Spitoni GF, Paolucci S, Iosa M (2020) Effect of different music genres on gait patterns in Parkinson’s disease. Neurol Sci 41:575–582. https://doi.org/10.1007/s10072-019-04127-4
doi: 10.1007/s10072-019-04127-4
pubmed: 31713758
Heiberger L, Maurer C, Amtage F, Mendez-Balbuena I, Schulte-Mönting J, Hepp-Reymond MC, Kristeva R (2011) Impact of a weekly dance class on the functional mobility and on the quality of life of individuals with Parkinson’s disease. Front Aging Neurosci 3:14. https://doi.org/10.3389/fnagi.2011.00014
doi: 10.3389/fnagi.2011.00014
pubmed: 22013420
pmcid: 3189543
Carlino E, Piedimonte A, Frisaldi E (2014) The effects of placebos and nocebos on physical performance. Handb Exp Pharmacol 225:149–157. https://doi.org/10.1007/978-3-662-44519-8_9
doi: 10.1007/978-3-662-44519-8_9
pubmed: 25304531
Galili DF (2015) Gaga: moving beyond technique with Ohad Naharin in the twenty-first century. Dance Chron 38:360–392. https://doi.org/10.1080/01472526.2015.1085759
doi: 10.1080/01472526.2015.1085759